Acylation stimulating protein is associated with pregnancy weight gain

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 4, 2008, Pages 33-43

  Sodowski, K ^a   Zwirska Korczala, Krystyna ^a   Kuka, D ^a   Kukla, M ^a   Budziszewska, P ^a   Zebaty, A ^a   Wender Ozegowska, E ^b   Baumert, M ^a   Wloch, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acylation stimulating protein (ASP); Adipose tissue; Obesity; Pregnancy

Indexed keywords

ACYLATION STIMULATING PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; LIPOGENESIS; NORMAL HUMAN; PREGNANCY; RANK SUM TEST; SECOND TRIMESTER PREGNANCY; WEIGHT GAIN;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; COMPLEMENT C3A; FEMALE; HUMANS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; WEIGHT GAIN; YOUNG ADULT;

EID: 53549088322     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Grundy SM, Cleeman JI, Daniels SR et al. American Heart Association/National Heart, Lung and Blood Institute. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752;
2. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Matab Clin North Am 2004; 33: 283-303;
3. Chew GT, Gan SK, Watts GF. Revisiting the metabolic syndrome. Med J Aust 2006; 185(8): 445-449;
4. Kukla M, Zwirska-Korczala K, Gabriel A et al. Liver tissue alterations in morbidly obese patients undergoing bariatric surgery. Exp Clin Hepatol 2007; 3(3): 12-18
5. Levin BE. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos Trans R Soc Lond B Biol Sci 2006; 361(1471): 1107-1121.
6. Sodowski K, Zwirska-Korczala K, Kuka D et al. Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women. J Physiol Pharmacol 2007;58(Suppl 1): 37-52.
7. Roselle L. Cripps, Malgorzata S. Martin-Gronert et al. Fetal and perinatal programming of appetite. Clin Sci 2005; 109, 1-11.
8. Maslowska M, Legakis H, Assadi F, Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res. 2006;47(3): 643-652.
9. Maslowska M, Wang HW, Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam Horm 2005; 70: 309-332.
10. Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol 2000; 11(3): 291-296.
11. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002; 13 ; 51-59.
12. Zwirska-Korczala K, Adamczyk-Sowa M, Sowa P et al. Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J Physiol Pharmacol 2007: 58(Suppl 1): 53-64.
13. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 2001; 21 ; 1034-1039.
14. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW, Cianflone K. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 2001; 25 ;705-771.
15. Cui W, Paglialunga S, Kalant D et al. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am J Physiol. 2007; 293(6): E1482-E1491.
16. Maslowska M, Legakis H, Assadi F, Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res. 2006; 47(3): 643-652.
17. Paglialunga S, Schrauwen P, Roy C et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol. 2007; 194(2): 293-304.
18. Paglialunga S, Fisette A, Yan Y et al. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol 2008; 294(3): E521-E529.
19. Maslowska M, Wang HW, Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam Horm 2005; 70: 309-332.
20. Saleh J, Summers LK, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998;39(4): 884-891.
21. Ahrén B, Havel PJ, Pacini G, Cianflone K. Acylation stimulating protein stimulates insulin secretion. Int J Obes Relat Metab Disord 2003; 27: 1037-1043.
22. Saleh J, Cianflone K, Chaudhary T, Al-Riyami H, Al-Abri AR, Bayoumi R. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity (Silver Spring) 2007; 15(3): 646-652.
23. Camera A, Hopps E, Caimi G. Metabolic syndrome: from insulin resistance to adipose tissue dysfunction. Minerva Med 2008; 99(3): 307-321.
24. Lann D, Gallagher E, Leroith D. Insulin resistance and the metabolic syndrome. Minerva Med 2008; 99(3): 253-262.
25. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 1(Suppl 5): 1256S-1261S.
26. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005; 280: 35983-35991.
27. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-knockout mice. Proc Natl Acad Sci U S A 2000; 97: 12729-12734.
28. Ueland T, Dalsoren T, Voldner N, Godang K, Henriksen T, Bollerslev J. RBP4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol. 2008; 159(1): 49-54.
29. Höckerstedt A, Jauhiainen M, Tikkanen MJ. Estradiol fatty acid esterification is increased in high density lipoprotein subclass 3 isolated from hypertriglyceridemic subjects. Atherosclerosis 2006; 185(2): 264-270.
30. Kuczmarski RJ, Carrol MD, Flegal KM et al. Varying body mass index cutoff points to describe overweight prevalence among US adults: National Health and Nutrition Examination Survey (NHANES) III (1988 to 1994). Obes Res 1997; 5: 542-548.
31. Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol 1982; 142: 735-738.
32. Paglialunga S, Fisette A, Yan Y et al. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol 2008; 294(3): E521-E529.
33. Paglialunga S, Schrauwen P, Roy C et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol 2007; 194(2): 293-304.
34. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53(Suppl 1): S143-S151.
35. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman A. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 2004; 45(1): 124-131.